Fresenius is a healthcare group spanning generic injectables (Kabi) and hospital operations (Helios). It trades on Frankfurt Stock Exchange (XETRA) under the ticker FRE, in the Healthcare sector.
Key Facts
| Item | Details |
|---|---|
| Ticker | FRE |
| Exchange | Frankfurt Stock Exchange (XETRA) (FRE) |
| Sector | Healthcare |
| Headquarters | Bad Homburg, Germany |
Bull Case & Risks
Bull Case
- Diversified healthcare exposure
- Kabi biosimilars growth
- Restructuring and deleveraging
Risks
- A complex, debt-heavy structure
- Hospital-cost and reimbursement pressure
Outlook
Fresenius is a diversified healthcare group simplifying and deleveraging, led by growth in Kabi biosimilars.
Educational information only, not investment advice. Stocks carry risk including possible loss of principal; past performance does not guarantee future results.